Pan-cancer investigation regarding the prognostic predictive and immunological regulation functions of PGK1 and experimental validation in esophageal squamous cell carcinoma
- 6 March 2025
- journal article
- research article
- Published by Springer Nature in Functional & Integrative Genomics
- Vol. 25 (1) , 1-21
Abstract
Phosphoglycerate kinase 1 (PGK1), a pivotal enzyme in the glycolysis pathway, contributes to tumor progression through diverse biological activities like cell metabolism, angiogenesis, proliferation, and epithelial-mesenchymal transformation (EMT). Although PGK1 has been intensively researched in specific cancer types, its overarching significance in pan-cancer contexts remains underexplored. This study leveraged various public database resources, including the Cancer Genome Atlas (TCGA), Genotype-Tissue Expression (GTEx), Tumor Immune Estimation Resource (TIMER2.0), and cBioPortal, to analyze the gene expression, gene alteration characteristics, prognostic value, subcellular localization, biological function, immune characteristics, and drug sensitivity of PGK1 in 33 different cancer types. R software was used to visualize these data. Furthermore, the effects of PGK1 on the proliferation, apoptosis, migration, and invasion of esophageal squamous cell carcinoma (ESCC) cells were also examined in vitro using 5-ethynyl-2′-deoxyuridine (EdU) incorporation assay, CCK-8 assay, Annexin V-FITC/PI assay, migration assay, and invasion assay. The findings suggested that PGK1 is upregulated in various cancer types and closely associated with poor prognosis. In terms of functional enrichment analysis, PGK1 primarily plays a role in glycolysis, hypoxia, EMT, and immune-related pathways. Furthermore, PGK1 is highly expressed in immune and malignant cells in the tumor microenvironment. Notably, PGK1 expression varied significantly among immune cells with distinct activation states. The results of experiments in vitro showed that PGK1 was significantly upregulated in ESCC cells, and its knockdown led to significant inhibition of proliferation, migration, and invasion while increasing cell apoptosis; conversely, overexpression promoted proliferation, migration, and invasion while reducing apoptosis. PGK1 can serve as a prognostic biomarker and therapy target for various cancers, and it may be a promising focal point of immunological studies.Keywords
Funding Information
- Central guidance local science and technology development program (24ZYQA029)
- National Key Research and Development Program of China (2022YFC2401500)
- Science and Technology Project of Lanzhou City (2023-1-9)
- Gansu Province Project of Science and Technologies (20JR10RA680)
- Lanzhou heavy Ion Accelerator High-end user Project (HIR20GY007)
This publication has 44 references indexed in Scilit:
- oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening dataBriefings in Bioinformatics, 2021
- Inflammation and tumor progression: signaling pathways and targeted interventionSignal Transduction and Targeted Therapy, 2021
- O-GlcNAcylation of PGK1 coordinates glycolysis and TCA cycle to promote tumor growthNature Communications, 2020
- Localisation of PGK1 determines metabolic phenotype to balance metastasis and proliferation in patients with SMAD4-negative pancreatic cancerGut, 2019
- miR‐548c‐5p inhibits colorectal cancer cell proliferation by targeting PGK1Journal of Cellular Physiology, 2019
- PGK1-mediated cancer progression and drug resistance2019
- Macrophage-Associated PGK1 Phosphorylation Promotes Aerobic Glycolysis and TumorigenesisMolecular Cell, 2018
- Mitochondria-Translocated PGK1 Functions as a Protein Kinase to Coordinate Glycolysis and the TCA Cycle in TumorigenesisMolecular Cell, 2016
- ComPPI: a cellular compartment-specific database for protein–protein interaction network analysisNucleic Acids Research, 2014
- Phosphoglycerate kinase 1‐overexpressing lung cancer cells reduce cyclooxygenase 2 expression and promote anti‐tumor immunity in vivoInternational Journal of Cancer, 2008